Department of Surgery, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Department of Radiology and Medical Imaging, King Khalid University Hospital and College of Medicine, King Saud University, Riyadh, Saudi Arabia.
JSLS. 2023 Jan-Mar;27(1). doi: 10.4293/JSLS.2022.00087.
Peritoneal dialysis (PD) is an accepted renal replacement therapy for end-stage renal disease (ESRD). Managing inguinal hernia in patients with PD is not standardized. Thus, this study reported the outcomes of simultaneous laparoscopic peritoneal dialysis catheter (PDC) placement and transabdominal preperitoneal (TAPP) repair of inguinal hernia.
Thirteen patients with chronic renal disease and inguinal hernia attending a tertiary hospital between May 1, 2016 and June 30, 2021 were evaluated for laparoscopic PDC placement. Concurrent laparoscopic inguinal herniorrhaphy and laparoscopic PDC placement were performed. Dialysate fluid was measured intraoperatively to the level below the incised peritoneum by 1 inch. The inflow and outflow was smooth without leakage. The amount was increased gradually in the two weeks after regular PD was obtained.
Laparoscopic PDC was inserted for 13 patients. Ten patients had unilateral hernia and two had bilateral inguinal hernia. Associated paraumbilical hernia was discovered in two patients. The median follow-up was 30 months. The measured safe amount of dialysate fluid intraoperatively was 400 - 600 mL. There was no death, intraoperative complication, or dialysate leakage. Three PDCs were removed owing to noncompliance. No hernia recurrence was observed.
Simultaneous laparoscopic PDC placement and laparoscopic repair of inguinal hernia with immediate dialysis is a safe and feasible surgical technique. Utilizing minimally invasive surgery affords PDC placement and inguinal hernia repair simultaneously.
腹膜透析(peritoneal dialysis,PD)是终末期肾病(end-stage renal disease,ESRD)的一种可接受的肾脏替代疗法。PD 患者的腹股沟疝的管理尚未标准化。因此,本研究报告了同期腹腔镜腹膜透析导管(peritoneal dialysis catheter,PDC)置管术和经腹腹膜前(transabdominal preperitoneal,TAPP)修补腹股沟疝的结果。
2016 年 5 月 1 日至 2021 年 6 月 30 日期间,在一家三级医院评估了 13 例患有慢性肾脏病和腹股沟疝的患者,以行腹腔镜 PDC 置管术。同期行腹腔镜腹股沟疝修补术和腹腔镜 PDC 置管术。术中测量腹膜透析液至切开腹膜下 1 英寸水平。流入和流出均无渗漏,且无阻力。在获得常规 PD 后两周内逐渐增加量。
13 例患者行腹腔镜 PDC 置管术。10 例患者为单侧疝,2 例为双侧腹股沟疝。2 例患者合并脐旁疝。中位随访时间为 30 个月。术中测量的安全腹膜透析液量为 400-600 mL。无死亡、术中并发症或透析液渗漏。因不遵医嘱,有 3 例 PDC 被移除。无疝复发。
同期腹腔镜 PDC 置管术和腹腔镜腹股沟疝修补术并即刻透析是一种安全可行的手术技术。微创外科技术可同时行 PDC 置管术和腹股沟疝修补术。